FC
CERE
Finepoint Capital’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-563,345
| Closed | -$12.3M | – | 28 |
|
|
2023
Q3 | $12.3M | Buy |
563,345
+70,800
| +14% | +$1.55M | 6.12% | 9 |
|
|
2023
Q2 | $15.7M | Sell |
492,545
-46,900
| -9% | -$1.49M | 5.42% | 9 |
|
|
2023
Q1 | $13.2M | Buy |
539,445
+22,158
| +4% | +$540K | 5.03% | 16 |
|
|
2022
Q4 | $16.3M | Sell |
517,287
-19,614
| -4% | -$619K | 5.27% | 12 |
|
|
2022
Q3 | $15.2M | Buy |
+536,901
| New | +$15.2M | 4.99% | 14 |
|